Clinical Trial Update: Weekly Docetaxel Plus Cisplatin as First-line Chemotherapy in Metastatic Salivary Gland Cancer Patients : a Multicenter Phase II Study [Phase 2]

View source ↗

Summary

A multicenter Phase II study evaluating weekly docetaxel plus cisplatin as first-line chemotherapy in metastatic salivary gland cancer is underway, with status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Salivary Gland Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Samsung Medical Center | Conditions: Salivary Gland Cancer | Phase 2 | Status: UNKNOWN